Haemonetics | HAE - Operating Profit

Stock Price
61.19
Daily Change
0.52 0.86%
Monthly
-12.72%
Yearly
-2.90%
Q1 Forecast
59.29

Haemonetics reported $67.4M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Cooper Companies USD 140.4M 35.3M Sep/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Hologic USD 237M 16M Dec/2025
ICU Medical USD 26.09M 770K Dec/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Neogen USD -5.38M 10.71M Sep/2025
OraSure Technologies USD -6M 3.26M Sep/2024
Quidel USD -37.3M 667.5M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
STAAR Surgical USD 18.49M 43.21M Sep/2025
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.97B 609M Dec/2025
Surmodics USD -5.64M 276K Sep/2024
Teleflex USD -408.9M 586.38M Sep/2025
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
US Physical Therapy USD 25.29M 281K Sep/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025